Not sure if this was posted about the conclusion highlights leronlimab's rapid antiviral effect and its potential as a salvage therapy component for MDR HIV when paired with OBT.


Link

https://pubmed.ncbi.nlm.nih.gov/39972543/

Joseph C Gathe et al. J Acquir Immune Defic Syndr. 2025.

The NCT05271370 extension study (58 participants)

I’ll have to confirm some things but just wanted to post it.